Diabetic Retinopathy-Another Possible Target for SGLT2 Inhibitors?
JAMA Ophthalmol
.
2024 Dec 5.
doi: 10.1001/jamaophthalmol.2024.5364.
Online ahead of print.
Authors
Jonathan E Shaw
1
2
3
,
Alicia J Jenkins
1
Affiliations
1
Baker Heart and Diabetes Institute, Diabetes and Population Health Research Laboratory, Melbourne, Victoria, Australia.
2
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
3
School of Life Sciences, La Trobe University, Bundoora, Victoria, Australia.
PMID:
39636630
DOI:
10.1001/jamaophthalmol.2024.5364
No abstract available